Getting Wegovy Through a Private Clinic in the UK — What's True and What Isn't

The clinic myth: why the building doesn't make the prescription legal

The most common misconception is that a private Wegovy prescription must come from a physical clinic. It doesn't. UK law requires a prescription issued by an appropriately registered prescriber following a genuine clinical assessment, the location of that assessment is secondary. The GPhC's pharmacy register is the measure that matters: if the pharmacy dispensing your semaglutide holds a current GPhC registration, and the prescriber reviewing your case is a GPhC-registered Independent Prescriber, the supply is lawful regardless of whether you ever set foot in a building.

This is worth stating plainly because a lot of marketing leans heavily on words like 'clinic' to imply exclusivity or safety. What actually signals safety is the clinical process: identity verification, a weight check that cannot be faked, a prescriber reading your health history rather than a form being rubber-stamped. At nume, every consultation is read by a real prescriber the same day. Our clinical team reviews the full picture, not an algorithm processing a tick-box form.

The same logic applies to red flags. If a seller is offering semaglutide without a prescription, with a suspiciously low price, or via social media with a discount code attached, none of those things are evidence of a legitimate clinic, and our Wegovy clinic page explains exactly what a regulated service should look like instead.

Who qualifies for Wegovy privately, and what the prescriber weighs up

Eligibility for a private Wegovy prescription follows the medicine's UK licence. Adults with a BMI of 30 or above qualify on BMI alone; those with a BMI between 27 and 29.9 qualify if they have at least one weight-related condition, which can include type 2 diabetes, hypertension, obstructive sleep apnoea, dyslipidaemia or cardiovascular disease. For some ethnic backgrounds, UK guidance applies thresholds around 2.5 kg/m² lower, a prescriber will factor that in.

BMI is the starting point, not the finish line. The prescriber also looks at your current medicines, medical history, and anything that might make semaglutide unsuitable, a history of pancreatitis, for instance, or certain conditions affecting the thyroid. Pregnancy, breastfeeding, and trying to conceive are all situations in which Wegovy is not recommended; the same applies to anyone under 18.

If you have been on semaglutide elsewhere and want to transfer, a clinical review still applies. Dose increases at any stage require the prescriber to see evidence that the current dose is being tolerated and that continuing makes clinical sense. The private Wegovy options available in the UK all operate within this framework, or should.

A question our prescribers hear regularly: does starting mid-week or just after payday change anything? No. Consultations run Monday to Friday, and the process is the same whether you submit a form on the 1st or the 28th of the month.

How the treatment schedule works in practice

Semaglutide starts at 0.25mg weekly and is titrated upward in stages, typically every four weeks, toward a maintenance dose. The previous standard maintenance was 2.4mg; following MHRA approval in April 2026, a dedicated single-dose 7.2mg pen is now available, offering a higher maintenance option for eligible adults with obesity. Clinical trial data reported around 20.7% average weight loss over 72 weeks at the 7.2mg dose, approaching results seen with tirzepatide 15mg in the SURMOUNT-5 head-to-head trial.

The earlier phases of the schedule serve a specific purpose: they allow your body to adjust to the medicine, which reduces the likelihood of gastrointestinal side effects like nausea, reflux, or loose stools in the first weeks. Those effects are common, particularly after a dose step, and tend to ease as the body settles. Persistent or severe abdominal pain, especially pain that spreads to the back, is different and needs prompt medical attention. For a full account of what to watch for, the NHS semaglutide medicines page is the clearest patient-level reference.

Wegovy is injected once weekly into the abdomen, thigh or upper arm, rotating sites each time. The pens are pre-filled and require refrigeration; the Patient Information Leaflet covers storage windows in full. On the private Wegovy injection process, the learning curve is genuinely short for most people.

Cost and what to look for in a legitimate service

Private Wegovy pricing varies by dose and provider. Eli Lilly raised Mounjaro's UK list price substantially from September 2025, and the broader private GLP-1 market shifted with it; semaglutide pricing from regulated UK pharmacies has typically ranged in a similar tier. No legitimate headline price includes the medicine alone, a consultation fee, prescriber review, and in many cases a delivery charge are separate items unless a provider states clearly that everything is bundled.

At nume, one price covers the consultation, the prescription, the medicine, and free next-working-day tracked delivery. There is no subscription, no auto-renewal, and no requirement to commit beyond a single order. Our Wegovy pricing page sets out current costs without per-pen figures scattered through articles. If you want to compare what different private services include, the private semaglutide landscape is worth reading before you decide.

One thing worth saying plainly: a low price is not a safety signal for a Prescription-Only Medicine. The MHRA has warned explicitly about counterfeit semaglutide pens sold through unofficial channels, fake pens have contained the wrong substances and caused hospitalisations. Checking any online pharmacy against the GPhC register takes about thirty seconds and is the clearest test of whether you are dealing with a regulated service.